{"id":12052,"date":"2025-05-21T10:46:23","date_gmt":"2025-05-21T10:46:23","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=12052"},"modified":"2025-05-21T10:46:23","modified_gmt":"2025-05-21T10:46:23","slug":"revolka-raises-1-4m-in-series-a-extension-for-therapies","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/","title":{"rendered":"RevolKa\u793e\u3001\u6cbb\u7642\u85ac\u306e\u30b7\u30ea\u30fc\u30baA\u62e1\u5f35\u3067$1.4M\u3092\u8abf\u9054"},"content":{"rendered":"<p>AI\u3092\u6d3b\u7528\u3057\u305f\u6700\u5148\u7aef\u306e\u30bf\u30f3\u30d1\u30af\u8cea\u5de5\u5b66\u6280\u8853\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u300caiProtein\u00ae\u300d\u3092\u63d0\u4f9b\u3059\u308b\u30d0\u30a4\u30aa\u30d9\u30f3\u30c1\u30e3\u30fc\u4f01\u696d\u3001\u30ec\u30dc\u30eb\u30ab\u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e\uff1a\u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u4ee3\u8868\u53d6\u7de0\u5f79\u793e\u9577\uff1a\u8fbb\u672c\u90a6\u5f66\u3001\u4ee5\u4e0b\u300c\u30ec\u30dc\u30eb\u30ab\u793e\u300d\uff09\u306f\u3001\u30b7\u30ea\u30fc\u30baA\u5ef6\u9577\u8cc7\u91d1\u3068\u3057\u30662\u51041,000\u4e07\u5186\uff08US$140\u4e07\u5186\uff09\u3092\u8abf\u9054\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u8cc7\u91d1\u8abf\u9054\u306b\u3088\u308a\u3001RevolKa\u306e\u5e0c\u5c11\u75be\u60a3\u5411\u3051\u5275\u85ac\u30d7\u30ed\u30b0\u30e9\u30e0\uff08https:\/\/www.revolka.com\/news\/english\/collab-en\/a65\uff09\u3092\u63a8\u9032\u3057\u3001\u5171\u540c\u63d0\u643a\u306e\u53d6\u308a\u7d44\u307f\u3092\u652f\u63f4\u3057\u307e\u3059\u3002\u4eca\u56de\u306e\u8cc7\u91d1\u8abf\u9054\u30e9\u30a6\u30f3\u30c9\u306f\u3001\u65e2\u5b58\u6295\u8cc7\u5bb6\u3067\u3042\u308bD3 LLC\u3068\u6771\u5317\u5927\u5b66\u30d9\u30f3\u30c1\u30e3\u30fc\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba\u682a\u5f0f\u4f1a\u793e\u304c\u5171\u540c\u3067\u4e3b\u5c0e\u3057\u3001DEEPCORE Inc.<\/p>\n<p>RevolKa\u793e\u306e\u30b3\u30a2\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3067\u3042\u308baiProtein\u00ae\u306f\u3001\u975e\u5e38\u306b\u9ad8\u6027\u80fd\u306a\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u5275\u88fd\u3059\u308b\u3001\u5f37\u56fa\u306aAI\u99c6\u52d5\u578b\u30bf\u30f3\u30d1\u30af\u8cea\u5de5\u5b66\u6280\u8853\u3067\u3059\u3002\u3053\u306e\u6280\u8853\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u30d1\u30fc\u30c8\u30ca\u30fc\u4f01\u696d\u3068\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u308a\u3001\u3059\u3067\u306b\u591a\u304f\u306e\u6210\u679c\u3092\u751f\u307f\u51fa\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30ec\u30dc\u30eb\u30ab\u304c\u72ec\u81ea\u306b\u958b\u767a\u3057\u305faiProtein\u00ae\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001AI\u306b\u3088\u308b\u30bf\u30f3\u30d1\u30af\u8cea\u5de5\u5b66\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002\u30bf\u30f3\u30d1\u30af\u8cea\u306f\u30a2\u30df\u30ce\u9178\u3068\u305d\u306e\u8a98\u5c0e\u4f53\u304b\u3089\u69cb\u6210\u3055\u308c\u308b\u7dda\u72b6\u9ad8\u5206\u5b50\u3067\u3042\u308a\u3001\u5185\u90e8\u306e\u8907\u96d1\u306a\u539f\u5b50\u9593\u76f8\u4e92\u4f5c\u7528\u306b\u3088\u3063\u3066\u4e09\u6b21\u69cb\u9020\u306b\u6298\u308a\u7573\u307e\u308c\u3001\u751f\u7269\u5b66\u7684\u6a5f\u80fd\u3092\u767a\u63ee\u3057\u307e\u3059\u3002\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u914d\u5217\u3001\u69cb\u9020\u3001\u6a5f\u80fd\u306e\u95a2\u4fc2\u306f\u307e\u3060\u5341\u5206\u306b\u7406\u89e3\u3055\u308c\u3066\u304a\u3089\u305a\u3001\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u5408\u7406\u7684\u306a\u8a2d\u8a08\u3092\u5236\u9650\u3057\u3066\u3044\u307e\u3059\u30022024\u5e74\u306b\u30ce\u30fc\u30d9\u30eb\u5316\u5b66\u8cde\u3092\u53d7\u8cde\u3057\u305fGoogle DeepMind\u304c\u958b\u767a\u3057\u305fAlphaFold\u306f\u3001\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u914d\u5217\u3068\u69cb\u9020\u306e\u95a2\u4fc2\u306bAI\u4e3b\u5c0e\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3057\u307e\u3057\u305f\u3002<\/p>\n<h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/fujifilm-finds-cancer-targeting-potential-in-new-peptides\/\" rel=\"bookmark\">\u5bcc\u58eb\u30d5\u30a4\u30eb\u30e0\u3001\u65b0\u898f\u30da\u30d7\u30c1\u30c9\u306b\u304c\u3093\u30bf\u30fc\u30b2\u30c3\u30c8\u306e\u53ef\u80fd\u6027\u3092\u898b\u51fa\u3059<\/a><\/h4>\n<p><a href=\"https:\/\/www.revolka.com\/\">\u30ec\u30dc\u30eb\u30ab<\/a>aiProtein\u00ae\u306eAI\u30a8\u30f3\u30b8\u30f3\u306f\u3001\u914d\u5217\u3068\u6a5f\u80fd\u306e\u95a2\u4fc2\u30c7\u30fc\u30bf\u306b\u57fa\u3065\u3044\u3066\u5b66\u7fd2\u3055\u308c\u3001\u6240\u671b\u306e\u6a5f\u80fd\u3092\u6301\u3064\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u914d\u5217\u3092\u52b9\u7387\u7684\u306b\u751f\u6210\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3055\u3089\u306b\u3001aiProtein\u00ae\u306f\u8907\u6570\u306e\u7279\u6027\u3092\u540c\u6642\u306b\u8a2d\u8a08\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u305f\u3081\u3001\u533b\u85ac\u54c1\u3084\u5de5\u696d\u7528\u9014\u306b\u9069\u3057\u305f\u65b0\u898f\u304b\u3064\u9ad8\u6a5f\u80fd\u306a\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u5275\u88fd\u3059\u308b\u305f\u3081\u306e\u5f37\u529b\u304b\u3064\u30b3\u30b9\u30c8\u52b9\u7387\u306e\u9ad8\u3044\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<p><strong>\u30bd\u30fc\u30b9 <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250515666172\/en\/RevolKa-Ltd.-Secures-210-million-JPY-US%241.4-million-Series-A-Extension-Funding-to-Advance-Therapeutic-Programs\">\u30d3\u30b8\u30cd\u30b9\u30ef\u30a4\u30e4\u30fc<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>RevolKa Ltd., a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform called aiProtein\u00ae, has raised 210 million JPY (US$1.4M) in Series A extension funding. This funding will advance RevolKa\u2019s drug discovery programs for rare diseases (https:\/\/www.revolka.com\/news\/english\/collab-en\/a65) and support collaborative partnering efforts. This financing round was co-led by existing investors, D3 LLC\u00a0 and TOHOKU University Venture Partners Co., Ltd. with participation from DEEPCORE Inc. RevolKa\u2019s core technology, aiProtein\u00ae is a robust AI-driven protein engineering technology that creates exceptionally high-performance proteins. This technology platform has already produced many successful outcomes in collaboration with partner companies. RevolKa\u2019s proprietary aiProtein\u00ae platform is an AI-assisted protein engineering platform. Proteins are linear polymers [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":12107,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,89,211,237,206],"tags":[4356,150,962,641,4357,873],"ppma_author":[205],"class_list":{"0":"post-12052","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-biotech","9":"category-health-tech","10":"category-japan","11":"category-news","12":"category-regional","13":"tag-aiprotein","14":"tag-biotech","15":"tag-data-management","16":"tag-investment","17":"tag-revolka","18":"tag-series-a-funding"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RevolKa Secures $1.4M to Advance Therapies<\/title>\n<meta name=\"description\" content=\"RevolKa Ltd. raises $1.4M in its Series A extension to boost AI-driven drug discovery for rare diseases and expand strategic partnerships.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RevolKa Secures $1.4M to Advance Therapies\" \/>\n<meta property=\"og:description\" content=\"RevolKa Ltd. raises $1.4M in its Series A extension to boost AI-driven drug discovery for rare diseases and expand strategic partnerships.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-21T10:46:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/05\/RevolKa-Ltd.-Secures-210-million-JPY-US_1.4-million-Series-A-Extension-Funding-to-Advance-Therapeutic-Programs.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ec\u30dc\u30eb\u30ab\u793e\u3001\u6cbb\u7642\u85ac\u958b\u767a\u306e\u305f\u3081\u306b$1.4M\u3092\u7372\u5f97","description":"RevolKa Ltd.\u304c\u30b7\u30ea\u30fc\u30baA\u3067$1.4M\u3092\u8abf\u9054\u3057\u3001\u5e0c\u5c11\u75be\u60a3\u306e\u305f\u3081\u306eAI\u4e3b\u5c0e\u306e\u5275\u85ac\u3092\u4fc3\u9032\u3057\u3001\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u62e1\u5927\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/","og_locale":"ja_JP","og_type":"article","og_title":"RevolKa Secures $1.4M to Advance Therapies","og_description":"RevolKa Ltd. raises $1.4M in its Series A extension to boost AI-driven drug discovery for rare diseases and expand strategic partnerships.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/","og_site_name":"itbusinesstoday","article_published_time":"2025-05-21T10:46:23+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/05\/RevolKa-Ltd.-Secures-210-million-JPY-US_1.4-million-Series-A-Extension-Funding-to-Advance-Therapeutic-Programs.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"RevolKa Raises $1.4M in Series A Extension for Therapies","datePublished":"2025-05-21T10:46:23+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/"},"wordCount":257,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/05\/RevolKa-Ltd.-Secures-210-million-JPY-US_1.4-million-Series-A-Extension-Funding-to-Advance-Therapeutic-Programs.webp","keywords":["aiProtein","Biotech","Data management","Investment","RevolKa","Series A funding"],"articleSection":["APAC","Biotech","Health Tech","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/","name":"\u30ec\u30dc\u30eb\u30ab\u793e\u3001\u6cbb\u7642\u85ac\u958b\u767a\u306e\u305f\u3081\u306b$1.4M\u3092\u7372\u5f97","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/05\/RevolKa-Ltd.-Secures-210-million-JPY-US_1.4-million-Series-A-Extension-Funding-to-Advance-Therapeutic-Programs.webp","datePublished":"2025-05-21T10:46:23+00:00","description":"RevolKa Ltd.\u304c\u5e0c\u5c11\u75be\u60a3\u306eAI\u5275\u85ac\u3092\u4fc3\u9032\u3057\u3001\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u62e1\u5927\u3059\u308b\u305f\u3081\u3001\u30b7\u30ea\u30fc\u30baA\u5897\u8cc7\u3092\u5b9f\u65bd\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/05\/RevolKa-Ltd.-Secures-210-million-JPY-US_1.4-million-Series-A-Extension-Funding-to-Advance-Therapeutic-Programs.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/05\/RevolKa-Ltd.-Secures-210-million-JPY-US_1.4-million-Series-A-Extension-Funding-to-Advance-Therapeutic-Programs.webp","width":1200,"height":800,"caption":"RevolKa"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/revolka-raises-1-4m-in-series-a-extension-for-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"RevolKa Raises $1.4M in Series A Extension for Therapies"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/12052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=12052"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/12052\/revisions"}],"predecessor-version":[{"id":12053,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/12052\/revisions\/12053"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/12107"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=12052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=12052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=12052"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=12052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}